Abstract
Keywords
CGNs Glutamate Neurotoxicity Scrophularia striata Neuroprotection
Introduction
Glutamate, the major excitatory neurotransmitter in CNS involved in fast synaptic transmission, neuronal plasticity, outgrowth and survival, memory, learning and behavior (1). However, it can be a potential neurotoxic substance at concentrations higher than normal level, resulting in neuron damage or death (2). Glutamate-mediated neurotoxicity appears to play a crucial role in several neuropathological disorders, particularly in Alzheimer’s disease, Parkinson’s disease, epilepsy and ischemic stroke (3). The most relevant biochemical events in glutamate-mediated neurotoxicity might be the acute influx of excess Ca2+ sequentially followed by over activation of Ca2+-dependent enzymes, such as nitric oxide synthesis (NOS), increased formation of reactive oxygen species (ROS) and lipid per oxidation (4, 5).
Many species of the genus Scrophularia (Scrophulariaceae) have been used traditionally as a remedy to cure illnesses such as scabies, tumors, eczema, psoriasis, inflammatory disorders fever, constipation, pharyngitis, neuritis and laryngitis affections (6-9).
Neuroprotective effects of some plants from this genus have been also considered in traditional medicine of Iran as well as some other countries such as South Korea (10). Neuroprotective (11) Cognitive-enhancing (10) and Anti-amnesic (12) properties of Scrophularia buergeriana have been reported previously. To date, many active components or crude extracts prepared from Scrophularia buergeriana roots have been reported to be neuroprotective potential in-vitro against glutamate excitotoxicity (11, 13). Scrophularia striata Boiss, another plant from this genus has been reported to have some of pharmacological effects such as Analgesic (14), Anti-microbial (15), nephroprotective (16) and nitric oxide suppressive (17) properties. Although this plant is commonly used in Iranian folk medicine for its neuroprotective effect, up to now, no study has been performed to investigate this effect using in-vitro/in-vivo biological instruments. Rat cerebellar granule neurons (CGNs) are the most common instrument in study of oxidative stress, excitotoxicity and preconditioning. In 8 days old rat neonates, CGNs are still developing, but have begun to express NMDA receptors (18). Culture of CGNs is well recognized as an effective tool for investigation in excitotoxicity (19).
In an attempt to find natural products with neuroprotective activity as a natural remedy against glutamate-mediated neurological disorders, we designed this study to evaluate the neuroprotective activity of total and sequential extracts from the aerial parts of Scrophulariastriata Boiss (Scrophulariaceae) on primary cultures of rat CGNs after exposure to the glutamate. To the best of our knowledge, this is the first evaluation of neuroprotective effect of this plant and the results of this study may help to find a useful and natural treatment to cure glutamate exitotoxicity-related disorders.
Experimental
Animals
Wister albino rats, weighing 200-250 g, were obtained from Pasteur Institute, Tehran, Iran. Animal experiments were conducted in accordance with current ethical regulations on animal research in Tehran University of Medical Sciences. Animals were randomized and housed in five plastic-based cages (40 × 26 × 15 cm3), each containing one male and two females, and were maintained under standard laboratory conditions (temperature of 20 ± 2°C, relative humidity of 40-45% and light-dark cycle of 12:12 h). Standard rat chow and tap water were available ad libitum.
Cell culture
Rat cerebellar granule neurons were prepared from 8 days old Sprague-Dawley rat as described previously (20). Briefly, neurons were dissociated from freshly dissected cerebellum by mechanical disruption in presence of Trypsin/ EDTA and 2400 U/mL DNase I and seeded into 0.1 mg/mL poly-D-lysine-coated hydrobromide in 24-well plastic plates at density of 1.25 × 106 Cells/mL in Basal modified Eagle’s medium supplemented with 10% fetal bovine serum (FBS), 25 mM KCl, 2 mM L-Glutamine and Gentamicin 0.1 mg/mL, and were incubated at 37°C in a humidified atmosphere of 95% air and 5% CO2. The replication of non-neuronal cells was prevented by adding 10 μM cytosine arabinoside 18-24 h after plating. Using this protocol, 95-99% of cultured cells were granule neurons (Figure 1). The experiments were performed after 8 days in culture.
Plant collection
The aerial parts of Scrophularia striata Boiss were collected from the northeastern part of Iran, in Ruin region. A sample was authenticated by Dr. F. Attar and a voucher specimen was preserved in the Faculty of Sciences’ Herbarium, Tehran University of Medical Sciences, Tehran, Iran (TUH No: 36501).
Total extract
Aerial parts of the plant were air-dried, powdered (100 g) and macerated with an 80% ethanol solution for 3 days with three changes of the solution. The resulting extract was filtered and evaporated under vacuum into a dried powder (10.3 g, 10.3%).
Sequential extracts
Solvents were from Merck Company. Different extracts were sequentially prepared using 500 g dried and powdered aerial parts of the plant with serial increase in polarity of solvents: petroleum ether (A, 3.3 g dry weight or responding to 0.6%) (bp.70-100°C), chloroform (B, 5.7 g dry weight corresponding to 1.1%), ethyl acetate (C, 6.4g dry weight corresponding to 1.2%) and 80% methanol solution (D, 8.2 dry weight corresponding to 1.6%). The extracts were dried under vacuum and dissolved in dimethyl sulfoxide (DMSO). The final concentration of DMSO was 0.1% (v/v) which was not toxic on the rat cortical neurons.
Morphological assay
For the light microscopy examinations, the cultures were washed with PBS and fixed with 10% formaldehyde for 5 min. Staining was performed using hematoxylin after being washed with PBS. Cells were washed again two times with PBS and were observed using an invert light microscope (Leitz Germany).
Determination of glutamate IC50
Selected cultures were exposed to a wide range of glutamate (5, 30, 50, 200, 500, 750 μM) for 12 h at room temperature in a standard Tris-buffered salt solution to calculate the IC50. Concentration of 125 μM was selected and used to continue the research.
Neuroprotection assay
All tested compounds were dissolved in DMSO and added to cell culture medium to bear the final concentrations of 0.1, 10, 25, 50, 75, 100 μg/mL. The final culture concentration of DMSO was 0.1% v/v which was not toxic for the cells. Neuronal viability was determined using MTT assay and IC50 was calculated. Concentration of 10 μM of compounds was selected to continue the project. Cultured CGNs were exposed to the medium containing the selected concentration of test compounds (10 μg/mL) for 1 h followed by exposure to the concentration of 125 μM of glutamate for 12 h. After washing, incubation was continued at concentration of 10 μg/mL of test fractions for 24 h. Neuronal viability was determined using MTT assay at 570 nm (690 nm reference wavelength).
Statistical analysis
Three independent experiments in triplicate were done for all assays (21). All data were expressed as mean ± SD of number of experiments. Statistical analysis was performed with one way analysis of variance (one way ANOVA) after confirmation of normal distribution, and group means were compared by post-hoc test of Tukey multiple comparisons of means. Values were considered statistically significant when p-value ≤ 0.05. Calculations of IC50 were made using the Microsoft office Excel and Sigma Plot version 11.0 (Systat Software, Inc.).
Results
Our results showed that glutamate has a cytotoxic effect on CGNs (Figure 2).
The application of glutamate, at concentrations over 5 μM for 12 h at 8 DIV caused a dosedependent reduction in neuronal viability up to a concentration of 750 μM, beyond which no further damage due to glutamate-mediated toxicity was observed (IC50 = 52.53). Cultured CGNs showed that the rounded cell bodies and phase-bright were severely damaged. Immediately after the brief exposure to glutamate, phase-contrast microscopy showed an increased darkness and granularity of cell bodies and by 24 h, most of the neurons had disappeared. It was noticeable that a relatively sharp drop in viability compared with the sham control was noted when the normally non-toxic concentration of 5 μM glutamate was applied, suggesting that the ‘sham control’ procedure may not have accounted for all of the damages inflicted by the treatment procedure. The presence of glutamate in Tris buffer causes a larger rise due to the release of endogenous neuronal glutamate and decreased of cell viability.
The IC50 for neuroprotective effects of the extracts were calculated as the doses at which 50% neuroprotective effects occurred compared to untreated control cells. Calculated IC50s for total and sequential fractions showed that none of the fractions showed cytotoxic effects on cultured CGNs at selected concentration for neuroprotective studies (Table 1).
Calculated IC50 for total and sequential fractions based on the data from cytotoxic assays.
| Extract | IC50 (mcg/mL) |
|---|---|
| Total extract | 30 |
| Chloroform fraction | > 100 |
| Methanolic fraction | > 100 |
| Ethyle acetate fraction | > 100 |
| Petroleum | > 100 |
All fractions showed a marginal inhibition of glutamate-induced neurotoxicity (Figure 3). As shown, of the five different fractions of Scrophularia striata Boiss, MeOH fraction was observed to have the most neuroprotective effect against glutamate-induced neurotoxicity in a dose-dependent manner.
Discussion
Scrophularia striata (Scrophulariaceae) is used traditionally as a medicinal herb in Iran and some other countries such as South Korea and china. Recently, some novel pharmacological actions of Scrophularia striata were discovered, such as antimicrobial effects (14), inhibitory effect on matrix metalloproteinase (MMPs) (22), suppression of NO production in activated murine peritoneal macrophages ex-vivo (16) and stimulatory effects on human fibroblast cells proliferation and on improvement of wound healing and anti-tumor activity (23). According to the literature, several Scrophularia species such as Scrophularia buergeriana have been investigated and found to contain some classes of secondary metabolites including iridous, phenylpropanoids, phenolic acids, flavonoid and saponins. Some of these compounds were shown to have different pharmacological and therapeutic effects including neuroprotective properties (11, 24). However, no study has been performed yet to investigate the neuroprotective effects of S. striata.
The initial purpose of the present study was to investigate the neuroprotective effect of Scrophularia striata Boiss extract against glutamate-induced neuronal injury in primary cultured rat CGNs. We observed a significant protective effect of MeOH fraction against glutamate neurotoxicity, although total EtOH extract and other studied fractions have also attenuated the glutamate neurotoxicity. Based on the literature, five known compounds, including cinnamic acid, three flavonoids (quercetin, isorhamnetin-3-O-rutinoside and nepitrin) and one phenylpropanoid glycoside (acteoside 1) were previously isolated from the extract of the aerial parts of S. striata from 80% methanolic fraction (25). Cinnamic acid and related compounds have been reported to attenuate glutamate-induced neurotoxicity. Flavonoids found in this plant have been showed to reduce oxidative stress which is one of the established mechanisms of glutamate-induced neurotoxicity. Since the best neuroprotective results were dominantly observed from methanolic fraction which contains these neuroprotective compounds, it could be possible that at least some part (of course not completely) of observed neuroprotective effect is a result of these compounds. However, more studies should be designed to find other compounds involved in this effect since the presented data about isolated compounds from the plat S. striata are not enough and this study is the first evaluation of neuroprotective properties of this plant. Detailed mechanism of this observed effect also remains as an open question and screening of genes and proteins whose expression levels are modified by long-term treatment with methanolic fraction may provide useful information concerning the molecular targets mediating neuroprotection.
Taken together, the extract from aerial parts of Scrophularia striata Boiss has neuroprotective effect and MeOH fraction showed the best result on CGNs against glutamate-induced neurotoxicity.
References
-
1.
Albright TD, Jessel TM, Kandel ER, Poster MI. Neural science: A century of progress and the mysteries that remain. Cell. 2000;Suppl 100:55.
-
2.
Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1998;1:623-634. [PubMed ID: 2908446].
-
3.
Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. New England J. Medicine. 1994;330:613-622.
-
4.
Choi DW. Glutamate neurotoxicity in cortical cell cultures is calcium dependent. Neuroscience Letters. 1985;58:293-297. [PubMed ID: 2413399].
-
5.
Weikert S, Freyer D, Weh M, Lsaev N, Busch C, Schultze J, Megow D, Dirnagl U. Rapid Ca2+ dependent NO- production form central nervous system cells in culture measured by NO- nitrite/ozone chemo luminescence. Brain Res. 1997;748:1-11. [PubMed ID: 9067439].
-
6.
Galindez JDS, Lanza D, Matellano F. Biologically active substances from the genus Scrophularia. Pharm.Biol. 2002;40:45-59.
-
7.
Header M, Henderson MRH. The physicians of myddfai: The Welsh herbal tradition. Bot. J. Scotl. 1994;46:623-627.
-
8.
Bas E, Recio MC, Manez S, Giner RM, Escandell JM, Lopez-Gines C, Rios JL. New insight into the inhibition of the inflammatory response to experimental delayed-type hypersensitivity reactions in mice by scropolioside A. Eur. J. of Pharmacol. 2007b;555:199-210. [PubMed ID: 17113578].
-
9.
Diaz AM, Abad MJ, Fernandez L, Silvan AM, De Santos J, Bermejo P. Phenylpropanoid glycosides from Scrophularia scorodonia: in-vitro anti-inflammatory activity. Life Sci. 2004;74:2515-2526. [PubMed ID: 15010262].
-
10.
Jeong EJ, Lee KY, Kim, SH, Sung SH, Kim YC. Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophulariabuergeriana in scopolamine-treated mice. Eur. J. Pharmacol. 2008;588:78-84. [PubMed ID: 18462717].
-
11.
Kim SR, Kim YC. Neuroprotective phenylpropanoid esters of rhamnose isolated from roots of Scrophularia buergeriana. Phytochemistery. 2000;54:503-509.
-
12.
Kim SR, Kang SY, Lee KY, Kim SH, Markelonis GJ, Oh TH, Kim YC. Anti-amnestic activity of E-pmethoxycinnamic acid from Scrophularia buergeriana. Cognitive Brain Res. 2003;17:454-461.
-
13.
Cho J, Joo NE, Kong JY, Jeong DY, Lee KD, Kang BS. Inhibition of excitotoxic neuronal death by methanol extract of Acori graminei rhizoma in cultured rat cortical neurons. J. Ethnopharmacol. 2000;73:31-37. [PubMed ID: 11025136].
-
14.
Sofiabadi M, Azadmehr A, Hajiaghaei R, Rezazadeh Sh, Ajdari Zarmehri H. The effect of ethanolic extract of Scrophularia striata on pain in male rats. J.Medicinal Plants. 2012;11:113-119.
-
15.
Bahrami AM, Ali V. Effects of Scrophularia striata ethanolic leaves extracts on Staphylococcus aureus. Int. J. Pharmacol. 2010;6:393-396.
-
16.
Zaheri M, Ebrahimi Vosta Kalai S, Cheraghi J. Protective effect of aerial parts extract of scrophularia striata on cadmium and mercury-induced nephrotoxicity in rat. J. Babol University of MedicalSciences. 2011;13:48-53.
-
17.
Azadmehr A, Afshari A, Baradaran B, Hajiaghaee R, Rezazadeh S, Monsef-Esfahani H. Suppression of nitric oxide production in activated murine peritoneal macrophages in-vitro and ex-vivo by Scrophulariastriata ethanolic extract. J. Ethnopharmacol. 2009;6:166-9. [PubMed ID: 19527828].
-
18.
Vacas J, Fernandez M, Ros M, Blanco P. Adenosine modulation of (Ca2+) in cerebellar granular cells: multiple adenosine receptors involved. Brain Res. 2003;992:272-280. [PubMed ID: 14625066].
-
19.
Klimaviciusa L, Safiulina D, Kaasik A, Klusa V, Zharkovsky A. The effects of glutamate receptor antagonists on cerebellar granule cell survival and development. Neurotoxicology. 2008;29:101-8. [PubMed ID: 17981335].
-
20.
Freshney RI. Culture of animal cells, a manual of basic techniques. 5th ed. New Jersey, U.S.A: John Willy and sons, Inc; 2005. p. 408-413.
-
21.
Jing-Zi Liu, Bao-An Song, Hui-Tao Fan, Pinaki S, Wen-Ting Wan, Song Yang Al. Synthesis and in-vitro study of pseudo-peptide thioureas containing α-aminophosphonate moiety as potential antitumor agents. Eur. J. of Med. Chem. 2010;45:5108-5112. [PubMed ID: 20817326].
-
22.
Hajiaghaei R, Monsef-Esfahani HR, Khorramizadeh MR, Saadat F, Shahverdi AR, Attar F. Inhibitory Effect of Aerial Parts of Scrophularia striata on Matrix Metalloproteinases. Phototherapy Res. 2007;21:1127-1129.
-
23.
Ardeshiri Lajimi AAR, Barzegar M, Rezaei Tavirani M, Hashemi M, Heydari S, Moghadamnia SH, Jalantari H. Effects of Scrophularia striata extract on human fibroblast cells. Med. Sciences J. Islamic AzadUni. 2009;19:168-172.
-
24.
Kim SR, Lee KY, Koo KA, Sung SH, Lee NG, Kim JW. Four new neuroprotective iridoid glycosides from Scrophularia buergeriana roots. J. Nat. Prod. 2002;65:1696-1699. [PubMed ID: 12444706].
-
25.
Monsef-Esfahani H, Hajiaghaee R, Shahverdi AR, Khorramizadeh MR, Amini M. Flavonoids, Cinamic acid and Phenyl propanoids from aerial parts of Scrophularia striata. Pharmaceutical Biology. 2010;48:333-336. [PubMed ID: 20645822].